Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    October 2017
  1. EOH KJ, Paek J, Kim SW, Kim HJ, et al
    Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.
    Oncol Rep. 2017 Oct 11. doi: 10.3892/or.2017.6023.
    PubMed     Text format     Abstract available


    September 2017
  2. WANG Z, He S, Guo P, Guo X, et al
    MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer.
    Oncol Rep. 2017 Sep 20. doi: 10.3892/or.2017.5979.
    PubMed     Text format     Abstract available


  3. JIANG Y, Ren W, Wang W, Xia J, et al
    Inhibitor of beta-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/beta-catenin complex.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5962.
    PubMed     Text format     Abstract available


    August 2017
  4. LIANG H, Luo R, Chen X, Zhao Y, et al
    miR-187 inhibits the growth of cervical cancer cells by targeting FGF9.
    Oncol Rep. 2017 Aug 23. doi: 10.3892/or.2017.5916.
    PubMed     Text format     Abstract available


  5. DONG J, Su M, Chang W, Zhang K, et al
    Long non-coding RNAs on the stage of cervical cancer (Review).
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5905.
    PubMed     Text format     Abstract available


    July 2017
  6. LI X, Zhou Q, Tao L, Yu C, et al
    MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5832.
    PubMed     Text format     Abstract available


  7. LI X, Wang H, Du X, Yu W, et al
    Lactobacilli inhibit cervical cancer cell migration in vitro and reduce tumor burden in vivo through upregulation of E-cadherin.
    Oncol Rep. 2017 Jul 5. doi: 10.3892/or.2017.5791.
    PubMed     Text format     Abstract available


  8. WU X, Zhou J, Cai D, Li M, et al
    Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway.
    Oncol Rep. 2017 Jul 3. doi: 10.3892/or.2017.5787.
    PubMed     Text format     Abstract available


  9. ZHOU S, Xiao Y, Zhuang Y, Liu Y, et al
    Knockdown of homeobox containing 1 increases the radiosensitivity of cervical cancer cells through telomere shortening.
    Oncol Rep. 2017;38:515-521.
    PubMed     Text format     Abstract available


    June 2017
  10. LI Y, Zhang J, Han S, Qian Q, et al
    B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
    Oncol Rep. 2017 Jun 19. doi: 10.3892/or.2017.5730.
    PubMed     Text format     Abstract available


  11. XU X, Zou L, Yao Q, Zhang Y, et al
    Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3beta/p-Tyr216-GSK-3beta/beta-catenin axis.
    Oncol Rep. 2017 Jun 14. doi: 10.3892/or.2017.5721.
    PubMed     Text format     Abstract available


    May 2017
  12. LUAN X, Wang Y
    Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8.
    Oncol Rep. 2017 May 23. doi: 10.3892/or.2017.5663.
    PubMed     Text format     Abstract available


  13. OUYANG F, Liu J, Xia M, Lin C, et al
    GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
    Oncol Rep. 2017;37:2652-2662.
    PubMed     Text format     Abstract available


  14. LI W, Liang J, Zhang Z, Lou H, et al
    MicroRNA-329-3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
    Oncol Rep. 2017;37:2743-2750.
    PubMed     Text format     Abstract available


  15. SUN CY, Chu ZB, Huang J, Chen L, et al
    siRNA-mediated inhibition of endogenous brainderived neurotrophic factor gene modulates the biological behavior of HeLa cells.
    Oncol Rep. 2017;37:2751-2760.
    PubMed     Text format     Abstract available


    March 2017
  16. HAN S, Li Y, Zhang J, Liu L, et al
    Roles of immune inhibitory molecule B7-H4 in cervical cancer.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5481.
    PubMed     Text format     Abstract available


  17. LIN W, Feng M, Chen G, Zhou Z, et al
    Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
    Oncol Rep. 2017;37:1477-1486.
    PubMed     Text format     Abstract available


  18. DONG W, Sun S, Cao X, Cui Y, et al
    Exposure to TNFalpha combined with TGFbeta induces carcinogenesis in vitro via NF-kappaB/Twist axis.
    Oncol Rep. 2017;37:1873-1882.
    PubMed     Text format     Abstract available


    February 2017
  19. YIN Z, Sun Y, Ge S, Sun J, et al
    Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
    Oncol Rep. 2017 Feb 17. doi: 10.3892/or.2017.5463.
    PubMed     Text format     Abstract available


  20. YIN F, Wang N, Wang S, Yu F, et al
    HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Oncol Rep. 2017 Feb 17. doi: 10.3892/or.2017.5465.
    PubMed     Text format     Abstract available


  21. PANG X, Zhang Y, Zhang S
    High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
    Oncol Rep. 2017;37:831-840.
    PubMed     Text format     Abstract available


    November 2016
  22. SHI C, Zhang Z
    MicroRNA-362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5242.
    PubMed     Text format     Abstract available


    October 2016
  23. WU T, Chen X, Peng R, Liu H, et al
    Let7a suppresses cell proliferation via the TGFbeta/SMAD signaling pathway in cervical cancer.
    Oncol Rep. 2016 Oct 11. doi: 10.3892/or.2016.5160.
    PubMed     Text format     Abstract available


  24. ZHANG X, Cai D, Meng L, Wang B, et al
    MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
    Oncol Rep. 2016;36:2321-8.
    PubMed     Text format     Abstract available


    August 2016
  25. ZHANG M, Shi S, Guo R, Miao Y, et al
    Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5034.
    PubMed     Text format     Abstract available


  26. SHANG HS, Chang CH, Chou YR, Yeh MY, et al
    Curcumin causes DNA damage and affects associated protein expression in HeLa human cervical cancer cells.
    Oncol Rep. 2016 Aug 4. doi: 10.3892/or.2016.5002.
    PubMed     Text format     Abstract available


    July 2016
  27. PEI Z, Zeng J, Gao Y, Li F, et al
    Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression.
    Oncol Rep. 2016;36:291-8.
    PubMed     Text format     Abstract available


    May 2016
  28. DING Y, Yu AQ, Wang XL, Guo XR, et al
    Forced expression of Nanog with mRNA synthesized in vitro to evaluate the malignancy of HeLa cells through acquiring cancer stem cell phenotypes.
    Oncol Rep. 2016;35:2643-50.
    PubMed     Text format     Abstract available


    March 2016
  29. SHANG C, Zhu W, Liu T, Wang W, et al
    Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
    Oncol Rep. 2016 Mar 29. doi: 10.3892/or.2016.4715.
    PubMed     Text format     Abstract available


  30. ZHANG M, Xu Q, Yan S, Li Z, et al
    Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
    Oncol Rep. 2016 Mar 3. doi: 10.3892/or.2016.4651.
    PubMed     Text format     Abstract available


  31. YAO J, Deng B, Zheng L, Dou L, et al
    miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
    Oncol Rep. 2016;35:1645-51.
    PubMed     Text format     Abstract available


    February 2016
  32. HUANG C, Zhou L, Chang X, Pang X, et al
    B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
    Oncol Rep. 2016 Feb 2. doi: 10.3892/or.2016.4607.
    PubMed     Text format     Abstract available


  33. NISHI H, Sasaki T, Nagamitsu Y, Terauchi F, et al
    Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells.
    Oncol Rep. 2016;35:992-998.
    PubMed     Text format     Abstract available


    January 2016
  34. JIMENEZ-WENCES H, Martinez-Carrillo DN, Peralta-Zaragoza O, Campos-Viguri GE, et al
    Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4583.
    PubMed     Text format     Abstract available


    December 2015
  35. PEI Z, Zhu G, Huo X, Gao L, et al
    CD24 promotes the proliferation and inhibits the apoptosis of cervical cancer cells in vitro.
    Oncol Rep. 2015 Dec 24. doi: 10.3892/or.2015.4521.
    PubMed     Text format     Abstract available


    October 2015
  36. GONZALEZ-QUINTANA V, Palma-Berre L, Campos-Parra AD, Lopez-Urrutia E, et al
    MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).
    Oncol Rep. 2015 Oct 30. doi: 10.3892/or.2015.4369.
    PubMed     Text format     Abstract available


  37. SATO M, Kawana K, Fujimoto A, Yoshida M, et al
    Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.
    Oncol Rep. 2015 Oct 30. doi: 10.3892/or.2015.4367.
    PubMed     Text format     Abstract available


    September 2015
  38. SHANG WQ, Li H, Liu LB, Chang KK, et al
    RANKL/RANK interaction promotes the growth of cervical cancer cells by strengthening the dialogue between cervical cancer cells and regulation of IL-8 secretion.
    Oncol Rep. 2015 Sep 22. doi: 10.3892/or.2015.4303.
    PubMed     Text format     Abstract available


  39. TANAKA T, Terai Y, Kogata Y, Ashihara K, et al
    CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.
    Oncol Rep. 2015 Sep 8. doi: 10.3892/or.2015.4257.
    PubMed     Text format     Abstract available


    July 2015
  40. SONG X, Shi B, Huang K, Zhang W, et al
    miR-133a inhibits cervical cancer growth by targeting EGFR.
    Oncol Rep. 2015 Jul 2. doi: 10.3892/or.2015.4101.
    PubMed     Text format     Abstract available


    June 2015
  41. ZHU H, Abulimiti M, Liu H, Su XJ, et al
    RITA enhances irradiation-induced apoptosis in p53-defective cervical cancer cells via upregulation of IRE1alpha/XBP1 signaling.
    Oncol Rep. 2015 Jun 25. doi: 10.3892/or.2015.4083.
    PubMed     Text format     Abstract available


  42. XU J, Zhang W, Lv Q, Zhu D, et al
    Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN.
    Oncol Rep. 2015;33:3108-16.
    PubMed     Text format     Abstract available


  43. LIU S, Pan X, Yang Q, Wen L, et al
    MicroRNA-18a enhances the radiosensitivity of cervical cancer cells by promoting radiation-induced apoptosis.
    Oncol Rep. 2015;33:2853-62.
    PubMed     Text format     Abstract available


  44. BAI X, Ma Y, Zhang G
    Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway.
    Oncol Rep. 2015;33:3085-92.
    PubMed     Text format     Abstract available


    May 2015
  45. ZHAO Q, Zhai YX, Liu HQ, Shi YA, et al
    MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT.
    Oncol Rep. 2015 May 28. doi: 10.3892/or.2015.4013.
    PubMed     Text format     Abstract available


  46. KIM JY, Choi HE, Lee HH, Shin JS, et al
    Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G(2)/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.
    Oncol Rep. 2015;33:2639-47.
    PubMed     Text format     Abstract available


  47. ALDER S, Gustafsson S, Perinetti C, Mints M, et al
    Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV.
    Oncol Rep. 2015;33:2521-8.
    PubMed     Text format     Abstract available


    January 2015
  48. LI PX, Mu JH, Xiao HL, Li DH, et al
    Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma.
    Oncol Rep. 2015;33:125-32.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: